Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 and Its Resolution
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 130
- 试验地点
- 1
- 主要终点
- T CD8 lymphocytes
研究概览
简要总结
Prospective study to describe the immunological, metabolic and serologic profile in the acute and post acute phases of Coronavirus disease (COVID-19)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
T CD8 lymphocytes
时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers
Blood concentration of glucosidases
Metabolic markers
时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers
Blood concentration of glucosidases
Inflammatory markers
时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers
Blood concentration of glucosidases
Neutralizing antibodies
时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers
Blood concentration of glucosidases
次要结局
未报告次要终点
